The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.
U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.
The company presented in this investment proposal operates in the installation and maintenance of chemical and chemical-pharmaceutical plants. It is a family-owned limited liability company (S.r.l.), with two equal shareholders, each holding 50% of the shares. Both partners actively serve on the Board of Directors with delegated responsibilities in administrative, technical, and commercial areas.
Headquartered in Italy, the company was founded in the 1980s and has been in continuous operation for 37 years. It specializes in the installation and maintenance of chemical-pharmaceutical production facilities, with a particular focus on the construction and assembly of equipment connection piping. In addition to process plant and utility network installations, the company provides comprehensive maintenance services, with a strong emphasis on precise mechanical interventions.
The company has developed a robust quality management system, holding ISO 9001 certification, and complies with UNI EN 9606-1 welding standards, ensuring the quality and reliability of its welding procedures.
The owners are offering a 100% sale of the company shares, motivated by generational transition considerations.
With a solid base of loyal customers, a highly skilled team, and a strong reputation in the industry, the company is recognized as a reliable and established player in its market. The technical expertise and operational know-how developed over nearly four decades are highly transferable, making this an attractive investment opportunity.
Financials
Values in EUR/000
Description
FY 2024
%
FY 2023
%
FY 2022
%
FY 2021
%
Sales
4.972
100.0%
4.202
100.0%
3.695
100.0%
3.199
100.0%
EBITDA
192
3.9%
193
4.6%
62
1.7%
-30
-0.9%
Operating profit
164
3.3%
148
3.5%
48
1.3%
-38
-1.2%
Net profit
46
0.9%
10
0.2%
9
0.2%
-77
-2.4%
PFN
-779
-464
-282
-349
Board of Directors Compensation
-283
-5.7%
-286
-6.8%
-275
-7.4%
-272
-8.5%
Keypoints
In the period 2021–2024, the Company recorded a constant growth in turnover, going from € 3.2 million in 2021 to € 5.0 million in 2024, with a cumulative growth rate (CAGR) exceeding 15% per year.
This dynamic reflects:
– the recovery of post-Covid activity, with a return to pre-pandemic levels as early as 2023;
– strengthening the industrial customer portfolio, mainly in the chemical-pharmaceutical sector;
– the internalisation of services previously outsourced to third parties, with an increase in production capacity managed internally.
The growth in turnover was accompanied by a progressive improvement in EBITDA, which in 2024 stood at € 192 thousand (3.9%)
Financial strength is confirmed by an active net financial position (cash) of €779 thousand as of 31.12.2024, constantly growing in the last three financial years.
The annual net profit for 2024 is strongly influenced by the incidence of personnel costs, which account for 82.6%, to which must be added the 5.7% cost of directors’ compensation.
The company does not resort to bank debt, so the net financial position (PFN) for the year 2024 is represented by immediate current account liquidity of €779,000. During the year 2024, liquidity increased by approximately €314,000.
The company presented in this investment proposal operates in the installation and maintenance of chemical and chemical-pharmaceutical plants. It is a family-owned limited liability company (S.r.l.), with two equal shareholders, each holding 50% of the shares. Both partners actively serve on the Board of Directors with delegated responsibilities in administrative, technical, and commercial areas.
Headquartered in Italy, the company was founded in the 1980s and has been in continuous operation for 37 years. It specializes in the installation and maintenance of chemical-pharmaceutical production facilities, with a particular focus on the construction and assembly of equipment connection piping. In addition to process plant and utility network installations, the company provides comprehensive maintenance services, with a strong emphasis on precise mechanical interventions.
The company has developed a robust quality management system, holding ISO 9001 certification, and complies with UNI EN 9606-1 welding standards, ensuring the quality and reliability of its welding procedures.
The owners are offering a 100% sale of the company shares, motivated by generational transition considerations.
With a solid base of loyal customers, a highly skilled team, and a strong reputation in the industry, the company is recognized as a reliable and established player in its market. The technical expertise and operational know-how developed over nearly four decades are highly transferable, making this an attractive investment opportunity.
Financials
Values in EUR/000
Description
FY 2024
%
FY 2023
%
FY 2022
%
FY 2021
%
Sales
4.972
100.0%
4.202
100.0%
3.695
100.0%
3.199
100.0%
EBITDA
192
3.9%
193
4.6%
62
1.7%
-30
-0.9%
Operating profit
164
3.3%
148
3.5%
48
1.3%
-38
-1.2%
Net profit
46
0.9%
10
0.2%
9
0.2%
-77
-2.4%
PFN
-779
-464
-282
-349
Board of Directors Compensation
-283
-5.7%
-286
-6.8%
-275
-7.4%
-272
-8.5%
Keypoints
In the period 2021–2024, the Company recorded a constant growth in turnover, going from € 3.2 million in 2021 to € 5.0 million in 2024, with a cumulative growth rate (CAGR) exceeding 15% per year.
This dynamic reflects:
– the recovery of post-Covid activity, with a return to pre-pandemic levels as early as 2023;
– strengthening the industrial customer portfolio, mainly in the chemical-pharmaceutical sector;
– the internalisation of services previously outsourced to third parties, with an increase in production capacity managed internally.
The growth in turnover was accompanied by a progressive improvement in EBITDA, which in 2024 stood at € 192 thousand (3.9%)
Financial strength is confirmed by an active net financial position (cash) of €779 thousand as of 31.12.2024, constantly growing in the last three financial years.
The annual net profit for 2024 is strongly influenced by the incidence of personnel costs, which account for 82.6%, to which must be added the 5.7% cost of directors’ compensation.
The company does not resort to bank debt, so the net financial position (PFN) for the year 2024 is represented by immediate current account liquidity of €779,000. During the year 2024, liquidity increased by approximately €314,000.
Description
The company presented in this investment proposal operates in the installation and maintenance of chemical and chemical-pharmaceutical plants. It is a family-owned limited liability company (S.r.l.), with two equal shareholders, each holding 50% of the shares. Both partners actively serve on the Board of Directors with delegated responsibilities in administrative, technical, and commercial areas.
Headquartered in Italy, the company was founded in the 1980s and has been in continuous operation for 37 years. It specializes in the installation and maintenance of chemical-pharmaceutical production facilities, with a particular focus on the construction and assembly of equipment connection piping. In addition to process plant and utility network installations, the company provides comprehensive maintenance services, with a strong emphasis on precise mechanical interventions.
The company has developed a robust quality management system, holding ISO 9001 certification, and complies with UNI EN 9606-1 welding standards, ensuring the quality and reliability of its welding procedures.
The owners are offering a 100% sale of the company shares, motivated by generational transition considerations.
With a solid base of loyal customers, a highly skilled team, and a strong reputation in the industry, the company is recognized as a reliable and established player in its market. The technical expertise and operational know-how developed over nearly four decades are highly transferable, making this an attractive investment opportunity.
Financials
Values in EUR/000
Keypoints
This dynamic reflects:
– the recovery of post-Covid activity, with a return to pre-pandemic levels as early as 2023;
– strengthening the industrial customer portfolio, mainly in the chemical-pharmaceutical sector;
– the internalisation of services previously outsourced to third parties, with an increase in production capacity managed internally.
The growth in turnover was accompanied by a progressive improvement in EBITDA, which in 2024 stood at € 192 thousand (3.9%)
Basic Details
Target Price:
$3,000,000
Gross Revenue
$4,972,000
EBITDA
TBD
Business ID:
L#20250923
Country
Italy
Detail
Similar Businesses
Published on May 16, 2025 at 8:35 am. Updated on May 16, 2025 at 8:35 am
Waste Collection Recycling and Recovery Business
€1,600,000
Manufacturing
25-Year-Old Water Purification and Filtration Company
€6,000,000
Manufacturing
Motor and Sailing Yachts Manufacturing Business
$25,000,000
Manufacturing, Yatch & Boat Servicing & Repairs
Manufacturing Business of High Quality Patented Merchandising for Famous Football Clubs
$1,000,000
Manufacturing
50-Year-Old Cardboard box and flexible packaging Manufacturing Business
€9,500,000
Manufacturing
40-Year-Old Saudi Bakery Business
$37,000,000
Manufacturing
PREVIOUS PROPERTY
Washing Powder Manufacturing Business
NEXT PROPERTY
iOS Application for QR Code Scanning